10X GENOMICS INC
NASDAQ: TXG (10x Genomics, Inc.)
Kemas kini terakhir: 7 jam lalu21.20
-0.32 (-1.49%)
| Penutupan Terdahulu | 21.52 |
| Buka | 21.06 |
| Jumlah Dagangan | 2,718,720 |
| Purata Dagangan (3B) | 2,506,923 |
| Modal Pasaran | 2,691,471,360 |
| Harga / Jualan (P/S) | 4.27 |
| Harga / Buku (P/B) | 3.42 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Aug 2026 |
| Margin Keuntungan | -25.14% |
| Margin Operasi (TTM) | -31.33% |
| EPS Cair (TTM) | -1.30 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 9.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 11.33% |
| Nisbah Semasa (MRQ) | 5.37 |
| Aliran Tunai Operasi (OCF TTM) | 56.74 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 95.16 M |
| Pulangan Atas Aset (ROA TTM) | -12.43% |
| Pulangan Atas Ekuiti (ROE TTM) | -22.03% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Menurun | Bercampur |
| Health Information Services (Global) | Menurun | Bercampur | |
| Stok | 10x Genomics, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.88 |
|
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China). |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.93% |
| % Dimiliki oleh Institusi | 101.82% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 25.00 (Stifel, 17.93%) | Beli |
| Median | 22.50 (6.13%) | |
| Rendah | 20.00 (UBS, -5.66%) | Pegang |
| Purata | 22.50 (6.13%) | |
| Jumlah | 1 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 21.01 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Stifel | 02 Mar 2026 | 25.00 (17.92%) | Beli | 23.14 |
| UBS | 20 Feb 2026 | 20.00 (-5.66%) | Pegang | 18.88 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |